Guoxiang Zhou
Papers
1
Total Citations
2
H-Index
1
About
Dr. Guoxiang Zhou is a leading surgical oncologist whose research focuses on optimizing treatment outcomes for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies of minimally invasive versus open surgical techniques. His most impactful work addresses the ongoing clinical debate surrounding the optimal surgical approach for early-stage (BCLC 0/A) HCC. In a landmark 2025 nationwide cohort study, Dr. Zhou systematically compared clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection. This comprehensive analysis, already garnering early citations, provides crucial evidence for surgeons and policymakers by evaluating not only perioperative safety and oncologic efficacy but also the real-world cost implications of each modality. By rigorously examining these trade-offs, Dr. Zhou’s research helps guide surgical decision-making in an era of rapidly advancing technology. His work is particularly valuable for demonstrating how robotic and laparoscopic approaches may reduce hospital stays and complications while maintaining comparable oncologic outcomes to open surgery, though at higher upfront costs. Through these contributions, Dr. Zhou is helping to define evidence-based standards for the surgical management of HCC.
Research Focus
Key Achievements
Top Papers
- 1